Inactive Instrument
Sector Lightlake Therapeutics OTC Bulletin Board
Stocks
US53224T1051
Biotechnology & Medical Research
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 23-03-02 | Indivior completes acquisition of Opiant Pharmaceuticals | AN |
| 23-03-02 | Indivior Wraps Up Deal to Buy Opiant Pharmaceuticals | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.06% | +7.20% | +3.13% | +57.21% | +85.29% | +54.04% | +111.13% | +9.49% | - | 74.27B | |
| -2.29% | -1.51% | -3.29% | +2.80% | +16.60% | +33.30% | +75.15% | +209.56% | +5,416.83% | 61.21B | |
| +0.28% | +7.27% | +3.53% | +71.76% | +67.94% | +31.74% | +23.80% | -56.54% | - | 27.55B | |
| -2.20% | -3.52% | -4.61% | +15.78% | -32.04% | -18.65% | +358.77% | +328.83% | +701.29% | 26.38B | |
| -1.92% | +3.37% | -12.20% | +9.31% | +4.05% | +0.80% | -3.94% | -71.94% | - | 25.34B | |
| +0.57% | +3.66% | +8.52% | +34.15% | +13.07% | +25.59% | -9.08% | -18.92% | +100.52% | 20.84B | |
| -1.47% | +4.46% | -10.22% | +23.09% | +23.15% | -8.09% | +513.33% | - | - | 14.94B | |
| +1.29% | -2.49% | -16.07% | +19.03% | +177.32% | +163.31% | +333.06% | +1,388.09% | +653.35% | 15.17B | |
| -2.84% | -0.32% | +3.76% | +10.25% | +29.14% | +42.18% | +159.28% | +176.10% | +280.12% | 14.41B | |
| -4.53% | -5.20% | +28.83% | +15.09% | -6.23% | -14.36% | +754.17% | +204.83% | +87.86% | 13.66B | |
| -2.23% | -4.00% | -0.79% | -1.08% | -12.78% | +14.56% | +236.49% | +497.81% | +4,259.66% | 11.99B | |
| +1.67% | +2.36% | +8.03% | +17.54% | -13.72% | -25.57% | +160.00% | +133.25% | - | 11.26B | |
| -6.37% | +1.25% | -23.19% | -16.63% | +0.34% | +104.97% | +149.78% | +2.96% | +822.65% | 10.15B | |
| -2.97% | -5.51% | -14.94% | -18.05% | +3.19% | +35.06% | +118.71% | +95.09% | +648.52% | 9.4B | |
| -7.05% | +9.61% | +14.38% | +18.44% | +337.88% | +234.75% | +438.51% | -19.05% | - | 9.85B | |
| -6.10% | -5.53% | -10.26% | +6.85% | +20.33% | +67.48% | +9.21% | +112.07% | - | 8.78B | |
| -0.69% | +4.44% | -0.13% | +18.05% | +9.44% | -24.23% | +94.81% | -23.20% | - | 8.71B | |
| -5.03% | -4.91% | -18.71% | -10.67% | +164.64% | +441.17% | +645.44% | -55.37% | -46.57% | 8.11B | |
| -4.77% | -1.51% | +4.90% | +14.87% | +4.19% | +134.57% | +432.97% | - | - | 7.06B | |
| Average | -2.44% | +2.62% | -2.07% | +15.15% | +46.94% | +68.03% | +242.19% | +171.36% | +1,292.42% | 19.95B | |
| Weighted average by Cap. | -1.66% | +2.76% | -1.15% | +23.77% | +44.32% | +48.17% | +181.47% | +149.46% | +2,260.38% |
- Stock Market
- Stocks
- OPNT Stock
- Stock
- Sector Lightlake Therapeutics
Select your edition
All financial news and data tailored to specific country editions
